Product Program year 2025 Source: CMS Open Payments

Ebglyss

Drug Immunology

NDC 0002-7772-11

Open in the dashboard

General payments

$12,963,501

76,258 payments

Research payments

$0

0 payments

Through program year 2025, $12,963,501 in general payments and $0 in research payments were reported against Ebglyss (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $9,462,804 55,490
2024 General $3,500,698 20,768

Breakdown

Who paid General payments · program years 2024–2025
  1. Lilly USA, LLC $11,968,129 75,459 payments
  2. Eli Lilly and Company $991,499 635 payments
  3. Eli Lilly Export S.A. Puerto Rico Branch $3,874 164 payments
Top recipients General payments · program year 2025
  1. Bob Geng Allergy & Immunology · San Diego, CA $103,259 1% · 74 payments
  2. Andrea Suarez Berkeley, CA $99,009 1% · 1 payment
  3. Alexandra Golant Dermatology · New York, NY $96,767 1% · 64 payments
  4. Marcjonathan Serota Dermatology · Littleton, CO $93,054 <1% · 91 payments
  5. Jonathan Silverberg Dermatology · Washington, DC $91,844 <1% · 47 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $6,012,923 66% · 4,739 practitioners
  2. Physician Assistant $845,376 9% · 3,511 practitioners
  3. Physician Assistant, Medical Physician Assistant $502,997 6% · 950 practitioners
  4. Allergy & Immunology $489,844 5% · 617 practitioners
  5. Pediatric Dermatology Dermatology $256,480 3% · 45 practitioners

The top 5 of 99 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $1,309,090 14% · 1,256 recipients
  2. New York $886,325 9% · 1,022 recipients
  3. Texas $751,798 8% · 1,093 recipients
  4. Illinois $567,341 6% · 491 recipients
  5. Connecticut $461,385 5% · 189 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

76,258 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record